Newsbenzinga
Revolution Medicines Begins Phase 3 Trial For Advanced Lung Cancer Treatment
· Published
Article summary
Revolution Medicines doses first patients in its global Phase 3 trial testing zoldonrasib for metastatic non-small cell lung cancer.
An excerpt from the original article.
Comments —
Loading comments…